Metabolism and nutrition disorders: Not known: Hyperkalaemia.
Nervous system disorders: Common: Dizziness, orthostatic dizziness. Not known: Vertigo, headache.
Ear and labyrinth disorder: Not known: Tinnitus.
Cardiac disorders: Uncommon: Tachycardia.
Vascular disorders: Common: Orthostatic hypotension. Uncommon: Flushing.
Respiratory, thoracic and mediastinal disorders: Uncommon: Cough.
Gastrointestinal disorders: Common: Nausea/vomiting. Uncommon: Diarrhoea, dyspepsia/heartburn. Not known: Dysgeusia.
Hepatobiliary disorders: Uncommon: Jaundice. Not known: Hepatitis, abnormal liver function.
Blood and Lymphatic System Disorders: Not Known: Thrombocytopenia.
Skin and subcutaneous tissue disorders: Not known: Leukocytoclastic vasculitis.
Musculoskeletal and connective tissue disorders: Common: Musculoskeletal pain. Not known: Arthralgia, myalgia (in some cases associated with increased plasma creatine kinase levels), muscle cramps.
Renal and urinary disorders: Not known: Impaired renal function including cases of renal failure in patients at risk.
Reproductive system and breast disorders: Uncommon: Sexual dysfunction.
General disorders and administration site conditions: Common: Fatigue. Uncommon: Chest pain.
Investigations: Very common: Hyperkalaemia. Common: Significant increases in plasma creatine kinase.
Paediatric population: Headache, hypotension, dizziness, cough, increased creatinine and elevated CK values.
View ADR Monitoring Form